New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
10:05 EDTFMS, BAXBaxter denied Supreme Court appeal of Fresenius Medical ruling
The Supreme Court declined to hear an appeal filed by Baxter (BAX) over a patent dispute with Fresenius Medical (FMS). The high court decision means the Court of Appeals for the Federal Circuit's decision to overturn a lower court judgment of almost $24M in favor of Baxter remains intact. Reference Link
News For BAX;FMS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 22, 2014
09:03 EDTBAXBaxter submits application for FDA approval of BAX111
Subscribe for More Information
December 15, 2014
11:21 EDTFMSCytoSorbents enters strategic partnership with Fresenius Medical
CytoSorbents announced that they have entered into a multi-country strategic partnership with Fresenius Medical Care AG & CO KGaA to commercialize CytoSorbents' CytoSorb therapy. Under the terms of the agreement, Fresenius Medical Care will have the exclusive rights to distribute CytoSorb for critical care applications in France, Poland, Sweden, Denmark, Norway, and Finland. This multi-year agreement is subject to annual minimum guaranteed orders of CytoSorb to maintain exclusivity.
09:03 EDTBAXBaxter to divest Vero cell vaccines platform to Nanotherapeutics
Baxter International (BAX) announced that it has entered into a definitive agreement to sell its proprietary Vero cell technology and related assets, including its production facility in Bohumil, Czech Republic, to Nanotherapeutics, Inc. Financial details were not disclosed. The agreement with Nanotherapeutics includes all assets related to the platform, including vaccines for H5N1, H1N1 and seasonal influenza. The agreement also includes investigational vaccine programs for Ross River virus, Chikungunya disease and West Nile virus. In recent weeks, the company has also completed the sale of its commercial vaccines business and related manufacturing facilities to Pfizer (PFE).
December 11, 2014
07:40 EDTFMSBofA/Merrill to hold a field trip
European Medtech Field Trip is being held in Copenhagen, Denmark on December 11-12.
07:13 EDTFMSDanone to discuss whether to keep or sell medical nutrition unit, Reuters says
According to a source, Danone (DANOY) will hold a board meeting today to discuss whether to keep or sell its medical nutrition business, Reuters reports. Previous reports said Danone's board would decide whether to sell the unit to Hospira (HSP) or Fresenius (FMS), with Fresenius as the possible front-runner to enter exclusive talks. Reference Link
December 10, 2014
17:19 EDTBAXBaxter announces filing of Form 10 in connection with planned spin-off
Subscribe for More Information
December 9, 2014
12:22 EDTBAXPiper Jaffray biopharm analyst holds an analyst/industry conference call
Senior Research Analyst Schimmer, along with Biopharmaceuticals Analyst Breazzano, discuss gene therapy for hemophilia on an Analyst/Industry conference call to be held on December 11 at 10 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use